Shopping Cart 0
Cart Subtotal
AED 0

Meridian Bioscience Inc (VIVO) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1376

Details

Meridian Bioscience Inc (VIVO)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Meridian Bioscience Inc (Meridian) is a fully integrated life science company that develops, manufactures and distributes diagnostic test kits for viral, gastrointestinal, respiratory and parasitic infectious disease indications. It also manufactures bulk antigens, antibodies, purified reagents, nucleotides and related products for use in research and diagnostic manufacturing. The company develops proteins and other biological materials for use in biotechnology research for new drugs and vaccines. Meridian offers its products to acute care hospitals, outpatient clinics, reference laboratories and physician office laboratories in several countries worldwide. The company has presence in the US, Europe, Africa and the Middle East through direct offices and subsidiaries. Meridian is headquartered in Cincinnati, Ohio, the US.

Meridian Bioscience Inc Key Recent Developments

Jan 07,2019: Meridian Bioscience announces preliminary first quarter 2019 revenue; first quarter 2019 financial results Conference Call

Nov 08,2018: Meridian Bioscience reports fourth quarter and full-year operating results, sets fiscal 2019 cash dividend rate, and provides fiscal 2019 guidance

Nov 08,2018: Meridian Bioscience reports fourth quarter and full-year operating results, sets fiscal 2019 cash dividend rate, and provides fiscal 2019 guidance

Oct 09,2018: DiaSorin and Meridian Enter Into a Strategic Collaboration to Sell Helicobacter Pylori Stool Antigen Test in the United States and in the United Kingdom

Sep 24,2018: Meridian Bioscience announces retirement of John A. Kraeutler, executive chairman of the board; appoints David C. Phillips as chairman of the board; and elects Felicia Williams to the board of directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Meridian Bioscience Inc-Key Facts 6

Meridian Bioscience Inc-Key Employees 7

Meridian Bioscience Inc-Key Employee Biographies 8

Meridian Bioscience Inc-Major Products and Services 9

Meridian Bioscience Inc-History 13

Meridian Bioscience Inc-Company Statement 17

Meridian Bioscience Inc-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Section 2-Company Analysis 21

Company Overview 21

Meridian Bioscience Inc-Business Description 22

Business Segment: Diagnostics 22

Overview 22

Performance 22

Business Segment: Life Science 22

Overview 22

Performance 22

Geographical Segment: Americas 22

Performance 22

Geographical Segment: EMEA 23

Performance 23

Geographical Segment: ROW 23

Performance 23

R&D Overview 23

Meridian Bioscience Inc-SWOT Analysis 24

SWOT Analysis-Overview 24

Meridian Bioscience Inc-Strengths 24

Meridian Bioscience Inc-Weaknesses 25

Meridian Bioscience Inc-Opportunities 26

Meridian Bioscience Inc-Threats 27

Meridian Bioscience Inc-Key Competitors 28

Section 3-Company Financial Ratios 29

Financial Ratios-Capital Market Ratios 29

Financial Ratios-Annual Ratios 30

Performance Chart 33

Financial Performance 33

Financial Ratios-Ratio Charts 34

Section 4-Company's Lifesciences Financial Deals and Alliances 35

Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019 35

Meridian Bioscience Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019 36

Meridian Bioscience Inc, Recent Deals Summary 37

Section 5-Company's Recent Developments 38

Jan 07, 2019: Meridian Bioscience announces preliminary first quarter 2019 revenue; first quarter 2019 financial results Conference Call 38

Nov 08, 2018: Meridian Bioscience reports fourth quarter and full-year operating results, sets fiscal 2019 cash dividend rate, and provides fiscal 2019 guidance 39

Sep 24, 2018: Meridian Bioscience announces retirement of John A. Kraeutler, executive chairman of the board; appoints David C. Phillips as chairman of the board; and elects Felicia Williams to the board of directors 41

Jul 31, 2018: Meridian Bioscience reports third quarter 2018 operating results, declares regular third quarter cash dividend, and reaffirms fiscal 2018 guidance 42

Jul 27, 2018: Dynex Technologies announces global partnership with ZEUS Scientific 44

Apr 26, 2018: Meridian Bioscience Reports Second Quarter 2018 Operating Results, Declares Regular Second Quarter Cash Dividend, and Updates Fiscal 2018 Guidance 45

Mar 22, 2018: Statement from FDA's Donald St. Pierre on findings from ongoing investigation into lead testing issues 47

Mar 21, 2018: Meridian Bioscience Realigns Organizational Structure 48

Jan 25, 2018: Meridian Bioscience Reports Net Revenue Of USD 52.3 Million In Q1 fiscal 2018 49

Section 6-Appendix 52

Methodology 52

Ratio Definitions 52

About GlobalData 56

Contact Us 56

Disclaimer 56


List Of Figure

List of Figures

Meridian Bioscience Inc, Performance Chart (2014-2018) 33

Meridian Bioscience Inc, Ratio Charts 34

Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019 35

Meridian Bioscience Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019 36


List Of Table

List of Tables

Meridian Bioscience Inc, Key Facts 6

Meridian Bioscience Inc, Key Employees 7

Meridian Bioscience Inc, Key Employee Biographies 8

Meridian Bioscience Inc, Major Products and Services 9

Meridian Bioscience Inc, History 13

Meridian Bioscience Inc, Subsidiaries 19

Meridian Bioscience Inc, Key Competitors 28

Meridian Bioscience Inc, Ratios based on current share price 29

Meridian Bioscience Inc, Annual Ratios 30

Meridian Bioscience Inc, Annual Ratios (Cont...1) 31

Meridian Bioscience Inc, Annual Ratios (Cont...2) 32

Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019 35

Meridian Bioscience Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019 36

Meridian Bioscience Inc, Recent Deals Summary 37

Currency Codes 52

Capital Market Ratios 52

Equity Ratios 53

Profitability Ratios 53

Cost Ratios 54

Liquidity Ratios 54

Leverage Ratios 55

Efficiency Ratios 55

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Scivanta Medical Corp

Quidel Corp

Luminex Corp

Cepheid

Becton Dickinson and Co

Alere Inc

Company Profile

Company Profile Title

Meridian Bioscience Inc (VIVO)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Meridian Bioscience Inc (Meridian) is a fully integrated life science company that develops, manufactures and distributes diagnostic test kits for viral, gastrointestinal, respiratory and parasitic infectious disease indications. It also manufactures bulk antigens, antibodies, purified reagents, nucleotides and related products for use in research and diagnostic manufacturing. The company develops proteins and other biological materials for use in biotechnology research for new drugs and vaccines. Meridian offers its products to acute care hospitals, outpatient clinics, reference laboratories and physician office laboratories in several countries worldwide. The company has presence in the US, Europe, Africa and the Middle East through direct offices and subsidiaries. Meridian is headquartered in Cincinnati, Ohio, the US.

Meridian Bioscience Inc Key Recent Developments

Jan 07,2019: Meridian Bioscience announces preliminary first quarter 2019 revenue; first quarter 2019 financial results Conference Call

Nov 08,2018: Meridian Bioscience reports fourth quarter and full-year operating results, sets fiscal 2019 cash dividend rate, and provides fiscal 2019 guidance

Nov 08,2018: Meridian Bioscience reports fourth quarter and full-year operating results, sets fiscal 2019 cash dividend rate, and provides fiscal 2019 guidance

Oct 09,2018: DiaSorin and Meridian Enter Into a Strategic Collaboration to Sell Helicobacter Pylori Stool Antigen Test in the United States and in the United Kingdom

Sep 24,2018: Meridian Bioscience announces retirement of John A. Kraeutler, executive chairman of the board; appoints David C. Phillips as chairman of the board; and elects Felicia Williams to the board of directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Meridian Bioscience Inc-Key Facts 6

Meridian Bioscience Inc-Key Employees 7

Meridian Bioscience Inc-Key Employee Biographies 8

Meridian Bioscience Inc-Major Products and Services 9

Meridian Bioscience Inc-History 13

Meridian Bioscience Inc-Company Statement 17

Meridian Bioscience Inc-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Section 2-Company Analysis 21

Company Overview 21

Meridian Bioscience Inc-Business Description 22

Business Segment: Diagnostics 22

Overview 22

Performance 22

Business Segment: Life Science 22

Overview 22

Performance 22

Geographical Segment: Americas 22

Performance 22

Geographical Segment: EMEA 23

Performance 23

Geographical Segment: ROW 23

Performance 23

R&D Overview 23

Meridian Bioscience Inc-SWOT Analysis 24

SWOT Analysis-Overview 24

Meridian Bioscience Inc-Strengths 24

Meridian Bioscience Inc-Weaknesses 25

Meridian Bioscience Inc-Opportunities 26

Meridian Bioscience Inc-Threats 27

Meridian Bioscience Inc-Key Competitors 28

Section 3-Company Financial Ratios 29

Financial Ratios-Capital Market Ratios 29

Financial Ratios-Annual Ratios 30

Performance Chart 33

Financial Performance 33

Financial Ratios-Ratio Charts 34

Section 4-Company's Lifesciences Financial Deals and Alliances 35

Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019 35

Meridian Bioscience Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019 36

Meridian Bioscience Inc, Recent Deals Summary 37

Section 5-Company's Recent Developments 38

Jan 07, 2019: Meridian Bioscience announces preliminary first quarter 2019 revenue; first quarter 2019 financial results Conference Call 38

Nov 08, 2018: Meridian Bioscience reports fourth quarter and full-year operating results, sets fiscal 2019 cash dividend rate, and provides fiscal 2019 guidance 39

Sep 24, 2018: Meridian Bioscience announces retirement of John A. Kraeutler, executive chairman of the board; appoints David C. Phillips as chairman of the board; and elects Felicia Williams to the board of directors 41

Jul 31, 2018: Meridian Bioscience reports third quarter 2018 operating results, declares regular third quarter cash dividend, and reaffirms fiscal 2018 guidance 42

Jul 27, 2018: Dynex Technologies announces global partnership with ZEUS Scientific 44

Apr 26, 2018: Meridian Bioscience Reports Second Quarter 2018 Operating Results, Declares Regular Second Quarter Cash Dividend, and Updates Fiscal 2018 Guidance 45

Mar 22, 2018: Statement from FDA's Donald St. Pierre on findings from ongoing investigation into lead testing issues 47

Mar 21, 2018: Meridian Bioscience Realigns Organizational Structure 48

Jan 25, 2018: Meridian Bioscience Reports Net Revenue Of USD 52.3 Million In Q1 fiscal 2018 49

Section 6-Appendix 52

Methodology 52

Ratio Definitions 52

About GlobalData 56

Contact Us 56

Disclaimer 56


List Of Figure

List of Figures

Meridian Bioscience Inc, Performance Chart (2014-2018) 33

Meridian Bioscience Inc, Ratio Charts 34

Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019 35

Meridian Bioscience Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019 36


List Of Table

List of Tables

Meridian Bioscience Inc, Key Facts 6

Meridian Bioscience Inc, Key Employees 7

Meridian Bioscience Inc, Key Employee Biographies 8

Meridian Bioscience Inc, Major Products and Services 9

Meridian Bioscience Inc, History 13

Meridian Bioscience Inc, Subsidiaries 19

Meridian Bioscience Inc, Key Competitors 28

Meridian Bioscience Inc, Ratios based on current share price 29

Meridian Bioscience Inc, Annual Ratios 30

Meridian Bioscience Inc, Annual Ratios (Cont...1) 31

Meridian Bioscience Inc, Annual Ratios (Cont...2) 32

Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019 35

Meridian Bioscience Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019 36

Meridian Bioscience Inc, Recent Deals Summary 37

Currency Codes 52

Capital Market Ratios 52

Equity Ratios 53

Profitability Ratios 53

Cost Ratios 54

Liquidity Ratios 54

Leverage Ratios 55

Efficiency Ratios 55

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Scivanta Medical Corp

Quidel Corp

Luminex Corp

Cepheid

Becton Dickinson and Co

Alere Inc